| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | BICD2 GPHN MICAL1 MYH10 KIF21A MYO18A ARFGEF2 ARFGEF1 CORO1B DCTN1 TTLL7 MPRIP TBCB NEFM KIF9 MYO1F FMN2 GOLGA8B MACF1 KIF4B DLEC1 FMNL1 | 7.22e-06 | 1099 | 139 | 22 | GO:0008092 |
| GeneOntologyMolecularFunction | dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity | 4.81e-05 | 2 | 139 | 2 | GO:0106073 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.78e-04 | 118 | 139 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | actin filament binding | 1.94e-04 | 227 | 139 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | tubulin binding | KIF21A DCTN1 TTLL7 TBCB NEFM KIF9 FMN2 GOLGA8B MACF1 KIF4B DLEC1 | 2.07e-04 | 428 | 139 | 11 | GO:0015631 |
| GeneOntologyMolecularFunction | microtubule binding | 3.13e-04 | 308 | 139 | 9 | GO:0008017 | |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 4.75e-04 | 5 | 139 | 2 | GO:0141003 | |
| GeneOntologyMolecularFunction | molybdopterin cofactor binding | 7.09e-04 | 6 | 139 | 2 | GO:0043546 | |
| GeneOntologyMolecularFunction | R-SMAD binding | 7.63e-04 | 26 | 139 | 3 | GO:0070412 | |
| GeneOntologyBiologicalProcess | microtubule-based process | BICD2 CFAP91 ATRX TRIM58 KIF21A SUN1 HAUS5 APOB DZIP1 AP3B1 DCTN1 CDC14B TTLL7 TBCB NEFM KIF9 FMN2 GOLGA8B SASS6 MACF1 KIF4B PAX6 CCDC65 JHY | 1.81e-07 | 1058 | 140 | 24 | GO:0007017 |
| GeneOntologyBiologicalProcess | cell division | MYC DR1 MYH10 MIS18BP1 HAUS5 DCTN1 CDC14B TGFB2 USP8 NEK1 TIPIN EXOC6B FMN2 GOLGA8B KIF4B PAX6 YME1L1 KNL1 | 1.20e-06 | 697 | 140 | 18 | GO:0051301 |
| GeneOntologyBiologicalProcess | microtubule-based movement | BICD2 CFAP91 TRIM58 KIF21A SUN1 APOB DZIP1 AP3B1 DCTN1 NEFM KIF9 FMN2 KIF4B CCDC65 JHY | 1.36e-06 | 493 | 140 | 15 | GO:0007018 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | BICD2 CFAP91 ATRX SUN1 HAUS5 DZIP1 DCTN1 CDC14B TTLL7 TBCB NEFM FMN2 GOLGA8B SASS6 KIF4B PAX6 CCDC65 JHY | 1.90e-06 | 720 | 140 | 18 | GO:0000226 |
| GeneOntologyBiologicalProcess | nuclear migration | 3.18e-06 | 34 | 140 | 5 | GO:0007097 | |
| GeneOntologyBiologicalProcess | nucleus localization | 1.18e-05 | 44 | 140 | 5 | GO:0051647 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | MYC BICD2 ARHGEF19 TBC1D15 GPR65 ATRX HAUS5 ARFGEF1 BAZ1B CORO1B DZIP1 DCTN1 ZEB2 TGFB2 HOXA13 CRACD KIF9 MYO1F SASS6 ATM YME1L1 INO80B KNL1 | 3.54e-05 | 1342 | 140 | 23 | GO:0033043 |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | GPR65 ATRX TRIM58 MYO18A SHOX2 CORO1B DZIP1 DCTN1 ZEB2 PLEKHM1 ITPR1 TGFB2 HOXA13 CRACD USP8 PPP2R5D GOLGA8B SASS6 MACF1 ATM YME1L1 INO80B PROS1 | 4.65e-05 | 1366 | 140 | 23 | GO:0051130 |
| GeneOntologyBiologicalProcess | mitotic cell cycle | MYC MYH10 BAZ1B DCTN1 CDC14B RFWD3 HOXA13 USP8 RPTOR TIPIN RNF20 EXOC6B GOLGA8B SASS6 KIF4B HES1 ATM PAX6 KNL1 | 5.68e-05 | 1014 | 140 | 19 | GO:0000278 |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | MYC MYH10 BAZ1B DCTN1 CDC14B RFWD3 HOXA13 USP8 RPTOR TIPIN EXOC6B GOLGA8B SASS6 KIF4B ATM PAX6 KNL1 | 6.92e-05 | 854 | 140 | 17 | GO:1903047 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | MICAL1 MYH10 GPR65 DSP HAUS5 ARFGEF1 CORO1B DCTN1 ZEB2 TGFB2 TBCB NEFM CRACD USP8 MYO1F FMN2 GOLGA8B MYH16 | 8.62e-05 | 957 | 140 | 18 | GO:0097435 |
| GeneOntologyBiologicalProcess | cell cycle process | MYC MYH10 ATRX SUN1 HAUS5 CENPO BAZ1B DCTN1 CDC14B RFWD3 HOXA13 USP8 NEK1 RPTOR TIPIN EXOC6B FMN2 GOLGA8B SASS6 KIF4B ATM PAX6 KNL1 | 1.05e-04 | 1441 | 140 | 23 | GO:0022402 |
| GeneOntologyCellularComponent | supramolecular fiber | MICAL1 MYH10 DSP KIF21A HAUS5 MYO18A ARFGEF2 CORO1B DCTN1 RYR1 TTLL7 TBCB NEFM KIF9 MYO1F FMN2 GOLGA8B MACF1 KIF4B | 3.05e-04 | 1179 | 139 | 19 | GO:0099512 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | MICAL1 DSP KIF21A HAUS5 ARFGEF2 CORO1B DCTN1 TTLL7 TBCB NEFM KIF9 MYO1F FMN2 GOLGA8B MACF1 KIF4B | 3.22e-04 | 899 | 139 | 16 | GO:0099513 |
| GeneOntologyCellularComponent | supramolecular polymer | MICAL1 MYH10 DSP KIF21A HAUS5 MYO18A ARFGEF2 CORO1B DCTN1 RYR1 TTLL7 TBCB NEFM KIF9 MYO1F FMN2 GOLGA8B MACF1 KIF4B | 3.32e-04 | 1187 | 139 | 19 | GO:0099081 |
| GeneOntologyCellularComponent | neuronal cell body | GPHN MYH10 APOB GRIK4 DCTN1 TTLL7 ITPR1 TGFB2 NEFM RPTOR IGHMBP2 OLFM1 GOLGA8B VTI1B PDE11A | 4.52e-04 | 835 | 139 | 15 | GO:0043025 |
| MousePheno | ectopic neuron | 2.39e-06 | 48 | 114 | 6 | MP:0011723 | |
| MousePheno | abnormal nervous system development | MYC BICD2 GPHN PRRX1 MYH10 DSP SUN1 ARFGEF2 ARFGEF1 POU1F1 APOB DZIP1 DCTN1 ZEB2 ALG10B TGFB2 NEFM NEK1 ALG10 SASS6 HES1 PAX6 CCDC65 GCN1 JHY | 2.17e-05 | 1257 | 114 | 25 | MP:0003861 |
| MousePheno | ectopic Purkinje cell | 5.46e-05 | 26 | 114 | 4 | MP:0000885 | |
| MousePheno | absent cochlear microphonics | 6.08e-05 | 10 | 114 | 3 | MP:0004413 | |
| Domain | ARM-type_fold | ARFGEF2 ARFGEF1 APOB AP3B1 ITPR1 PPP2R5D PPP2R5E RPTOR ATM GCN1 FMNL1 | 3.87e-05 | 339 | 136 | 11 | IPR016024 |
| Domain | Alg10 | 5.26e-05 | 2 | 136 | 2 | IPR016900 | |
| Domain | DIE2_ALG10 | 5.26e-05 | 2 | 136 | 2 | PF04922 | |
| Domain | Homeodomain-like | ONECUT2 PRRX1 MIS18BP1 POU1F1 SHOX2 MIDEAS TTF1 ZEB2 HOXA13 PAX6 | 1.62e-04 | 332 | 136 | 10 | IPR009057 |
| Domain | DCB_dom | 3.13e-04 | 4 | 136 | 2 | IPR032629 | |
| Domain | Sec7_C | 3.13e-04 | 4 | 136 | 2 | IPR015403 | |
| Domain | DUF1981 | 3.13e-04 | 4 | 136 | 2 | PF09324 | |
| Domain | Sec7_N | 3.13e-04 | 4 | 136 | 2 | IPR032691 | |
| Domain | Sec7_N | 3.13e-04 | 4 | 136 | 2 | PF12783 | |
| Domain | DCB | 3.13e-04 | 4 | 136 | 2 | PF16213 | |
| Domain | PP2A_B56 | 5.19e-04 | 5 | 136 | 2 | IPR002554 | |
| Domain | B56 | 5.19e-04 | 5 | 136 | 2 | PF01603 | |
| Domain | ZF_PHD_2 | 6.52e-04 | 95 | 136 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 6.84e-04 | 96 | 136 | 5 | PS01359 | |
| Domain | RIH_assoc-dom | 7.75e-04 | 6 | 136 | 2 | IPR013662 | |
| Domain | - | 7.75e-04 | 6 | 136 | 2 | 3.90.1290.10 | |
| Domain | Ins145_P3_rec | 7.75e-04 | 6 | 136 | 2 | PF08709 | |
| Domain | RIH_assoc | 7.75e-04 | 6 | 136 | 2 | PF08454 | |
| Domain | RIH_dom | 7.75e-04 | 6 | 136 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 7.75e-04 | 6 | 136 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 7.75e-04 | 6 | 136 | 2 | IPR015925 | |
| Domain | - | 7.75e-04 | 6 | 136 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 7.75e-04 | 6 | 136 | 2 | PF01365 | |
| Domain | Plectin | 1.08e-03 | 7 | 136 | 2 | PF00681 | |
| Domain | Plectin_repeat | 1.08e-03 | 7 | 136 | 2 | IPR001101 | |
| Domain | PLEC | 1.08e-03 | 7 | 136 | 2 | SM00250 | |
| Domain | - | 1.11e-03 | 283 | 136 | 8 | 1.10.10.60 | |
| Domain | - | 1.22e-03 | 222 | 136 | 7 | 1.25.10.10 | |
| Domain | Zinc_finger_PHD-type_CS | 1.29e-03 | 65 | 136 | 4 | IPR019786 | |
| Domain | TMC | 1.43e-03 | 8 | 136 | 2 | PF07810 | |
| Domain | TMC | 1.43e-03 | 8 | 136 | 2 | IPR012496 | |
| Domain | HOMEOBOX_1 | 1.73e-03 | 236 | 136 | 7 | PS00027 | |
| Domain | HOX | 1.77e-03 | 237 | 136 | 7 | SM00389 | |
| Domain | IQ | 1.79e-03 | 71 | 136 | 4 | PF00612 | |
| Domain | HOMEOBOX_2 | 1.86e-03 | 239 | 136 | 7 | PS50071 | |
| Domain | Homeobox_dom | 1.86e-03 | 239 | 136 | 7 | IPR001356 | |
| Domain | Prefoldin | 1.89e-03 | 72 | 136 | 4 | IPR009053 | |
| Domain | Myb_DNA-binding | 2.08e-03 | 35 | 136 | 3 | PF00249 | |
| Domain | MIR | 2.28e-03 | 10 | 136 | 2 | PF02815 | |
| Domain | CAP_GLY | 2.28e-03 | 10 | 136 | 2 | PF01302 | |
| Domain | MIR_motif | 2.28e-03 | 10 | 136 | 2 | IPR016093 | |
| Domain | CAP_GLY | 2.28e-03 | 10 | 136 | 2 | SM01052 | |
| Domain | - | 2.28e-03 | 10 | 136 | 2 | 2.30.30.190 | |
| Domain | MIR | 2.28e-03 | 10 | 136 | 2 | PS50919 | |
| Domain | MIR | 2.28e-03 | 10 | 136 | 2 | SM00472 | |
| Domain | CAP_GLY_1 | 2.28e-03 | 10 | 136 | 2 | PS00845 | |
| Domain | CAP_GLY_2 | 2.28e-03 | 10 | 136 | 2 | PS50245 | |
| Domain | CAP-Gly_domain | 2.28e-03 | 10 | 136 | 2 | IPR000938 | |
| Domain | Myosin_head_motor_dom | 2.64e-03 | 38 | 136 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 2.64e-03 | 38 | 136 | 3 | PS51456 | |
| Domain | MYB_LIKE | 2.64e-03 | 38 | 136 | 3 | PS50090 | |
| Domain | Myosin_head | 2.64e-03 | 38 | 136 | 3 | PF00063 | |
| Domain | MYSc | 2.64e-03 | 38 | 136 | 3 | SM00242 | |
| Domain | Znf_PHD-finger | 2.65e-03 | 79 | 136 | 4 | IPR019787 | |
| Domain | IQ | 2.90e-03 | 81 | 136 | 4 | SM00015 | |
| Domain | Kinesin_motor_CS | 3.29e-03 | 41 | 136 | 3 | IPR019821 | |
| Domain | THAP | 3.31e-03 | 12 | 136 | 2 | SM00980 | |
| Domain | THAP | 3.31e-03 | 12 | 136 | 2 | PF05485 | |
| Domain | ZF_THAP | 3.31e-03 | 12 | 136 | 2 | PS50950 | |
| Domain | DM3 | 3.31e-03 | 12 | 136 | 2 | SM00692 | |
| Domain | Znf_C2CH | 3.31e-03 | 12 | 136 | 2 | IPR006612 | |
| Domain | ARM-like | 3.66e-03 | 270 | 136 | 7 | IPR011989 | |
| Domain | Kinesin-like_fam | 3.77e-03 | 43 | 136 | 3 | IPR027640 | |
| Domain | - | 4.02e-03 | 44 | 136 | 3 | 3.40.850.10 | |
| Domain | Kinesin | 4.02e-03 | 44 | 136 | 3 | PF00225 | |
| Domain | KISc | 4.02e-03 | 44 | 136 | 3 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 4.02e-03 | 44 | 136 | 3 | PS00411 | |
| Domain | Kinesin_motor_dom | 4.02e-03 | 44 | 136 | 3 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 4.02e-03 | 44 | 136 | 3 | PS50067 | |
| Domain | PHD | 4.07e-03 | 89 | 136 | 4 | SM00249 | |
| Domain | IQ_motif_EF-hand-BS | 4.24e-03 | 90 | 136 | 4 | IPR000048 | |
| Domain | Znf_PHD | 4.41e-03 | 91 | 136 | 4 | IPR001965 | |
| Domain | Znf_FYVE_PHD | 4.45e-03 | 147 | 136 | 5 | IPR011011 | |
| Domain | IQ | 4.76e-03 | 93 | 136 | 4 | PS50096 | |
| Domain | FH2 | 5.19e-03 | 15 | 136 | 2 | PS51444 | |
| Domain | FH2_Formin | 5.19e-03 | 15 | 136 | 2 | IPR015425 | |
| Domain | FH2 | 5.19e-03 | 15 | 136 | 2 | PF02181 | |
| Domain | OAR | 5.19e-03 | 15 | 136 | 2 | PF03826 | |
| Domain | - | 5.19e-03 | 15 | 136 | 2 | 1.10.1000.11 | |
| Domain | Sec7 | 5.19e-03 | 15 | 136 | 2 | PF01369 | |
| Domain | Sec7_alpha_orthog | 5.19e-03 | 15 | 136 | 2 | IPR023394 | |
| Domain | FH2 | 5.19e-03 | 15 | 136 | 2 | SM00498 | |
| Domain | ConA-like_dom | 5.40e-03 | 219 | 136 | 6 | IPR013320 | |
| Domain | - | 5.65e-03 | 449 | 136 | 9 | 3.30.40.10 | |
| Domain | SANT | 5.77e-03 | 50 | 136 | 3 | SM00717 | |
| Domain | OAR | 5.91e-03 | 16 | 136 | 2 | PS50803 | |
| Domain | SEC7 | 5.91e-03 | 16 | 136 | 2 | PS50190 | |
| Domain | OAR_dom | 5.91e-03 | 16 | 136 | 2 | IPR003654 | |
| Domain | Sec7 | 5.91e-03 | 16 | 136 | 2 | SM00222 | |
| Domain | Sec7_dom | 5.91e-03 | 16 | 136 | 2 | IPR000904 | |
| Domain | SANT/Myb | 6.43e-03 | 52 | 136 | 3 | IPR001005 | |
| Domain | Znf_RING/FYVE/PHD | 6.49e-03 | 459 | 136 | 9 | IPR013083 | |
| Domain | RING | 7.05e-03 | 305 | 136 | 7 | SM00184 | |
| Pubmed | BICD2 CFAP91 REPS1 ATRX DSP POLG KIF21A ARFGEF2 DNAAF9 DZIP1 NUP42 CCDC6 DCTN1 ZEB2 MPRIP NEFM THAP4 USP8 PPP2R5E PTPRA DROSHA MRPS9 OLFM1 FMN2 MACF1 ATM PAX6 YME1L1 DOP1B | 4.31e-14 | 1285 | 141 | 29 | 35914814 | |
| Pubmed | GPHN TBC1D15 REPS1 RAPH1 DSP HAUS5 BAZ1B CORO1B AP3B1 MIDEAS DCTN1 NSD3 MPRIP NEFM NEK1 PHF3 GCN1 | 1.07e-10 | 549 | 141 | 17 | 38280479 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | GPHN CFAP91 ATRX IARS1 EI24 CORO1B AP3B1 DCTN1 MTPAP MPRIP LPIN3 NEFM USP8 NEK1 PPP2R5D PPP2R5E RPTOR EXOC6B GCN1 YME1L1 NEURL4 PKN3 VTI1B | 3.82e-09 | 1321 | 141 | 23 | 27173435 |
| Pubmed | MYH10 RAPH1 DSP SUN1 TAB2 CCDC6 AP3B1 CDC14B NSD3 ITPR1 PPP2R5D PPP2R5E PTPRA FMN2 HERC1 USP1 GCN1 YME1L1 NEURL4 KNL1 | 9.95e-09 | 1049 | 141 | 20 | 27880917 | |
| Pubmed | DR1 MYH10 ERCC5 ATRX RAPH1 DSP TTC16 KIF21A MYO18A APOB DCTN1 ZEB2 TBCB CCDC27 NEFM USP8 MRPS9 MACF1 DLEC1 ATM ABCC2 PLCH1 USP1 | 1.94e-08 | 1442 | 141 | 23 | 35575683 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GPHN MYH10 REPS1 ATRX RAPH1 DSP BAZ1B CORO1B DCTN1 MPRIP TBCB CRACD USP8 NEK1 MACF1 GCN1 PKN3 KNL1 | 4.95e-08 | 934 | 141 | 18 | 33916271 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | BICD2 MYH10 MIS18BP1 RAPH1 BMP2K DSP HAUS5 TAB2 CORO1B DCTN1 MTPAP PDHX TBCB PPP2R5D BRPF1 SASS6 NEURL4 | 7.45e-08 | 853 | 141 | 17 | 28718761 |
| Pubmed | 8.36e-08 | 11 | 141 | 4 | 32950463 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GPHN RAPH1 DSP TAB2 DZIP1 CCDC6 NSD3 MPRIP LPIN3 USP8 NEK1 PHF3 RPTOR FMN2 MACF1 PLCH1 DOP1B | 8.50e-08 | 861 | 141 | 17 | 36931259 |
| Pubmed | BICD2 TBC1D15 RAPH1 DSP SUN1 EI24 CORO1B NUP42 AP3B1 ITPR1 TBCB GCN1 FMNL1 VTI1B | 8.88e-08 | 568 | 141 | 14 | 37774976 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | BICD2 MIS18BP1 ATRX DSP BAZ1B TAB2 NUP42 CCDC6 MPRIP DROSHA RPTOR SASS6 MACF1 KNL1 | 1.35e-07 | 588 | 141 | 14 | 38580884 |
| Pubmed | GPHN TBC1D15 SUN1 ARFGEF2 ARFGEF1 NUP42 PLEKHM1 ITPR1 RPTOR FMN2 YME1L1 VTI1B DOP1B | 1.56e-07 | 504 | 141 | 13 | 34432599 | |
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 22084092 | ||
| Pubmed | Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex. | 4.00e-07 | 37 | 141 | 5 | 27565344 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ARHGEF19 REPS1 POLG TMC6 ARFGEF2 CORO1B DCTN1 CDC14B PLEKHM1 RYR1 NSD3 MPRIP LPIN3 RPTOR NLRC5 HERC1 GCN1 PKN3 | 5.84e-07 | 1105 | 141 | 18 | 35748872 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | BICD2 PDE4C ERCC5 ATRX RAPH1 DSP MYO18A ARFGEF2 BAZ1B CCDC6 PHF3 RPTOR BRPF1 RNF20 ATM | 6.50e-07 | 774 | 141 | 15 | 15302935 |
| Pubmed | MYC DR1 MYH10 DSP MKNK2 MYO18A NUP42 MIDEAS DCTN1 NSD3 MACF1 GCN1 | 7.58e-07 | 486 | 141 | 12 | 20936779 | |
| Pubmed | BICD2 GPHN MYH10 DSP IARS1 SUN1 MYO18A CORO1B PDHX ITPR1 TBCB PPP2R5D RPTOR IGHMBP2 MRPS9 OLFM1 MACF1 GCN1 | 9.01e-07 | 1139 | 141 | 18 | 36417873 | |
| Pubmed | NPR1 MYH10 ATRX ARFGEF2 TTF1 DCTN1 ZEB2 PPP2R5E DROSHA MACF1 HERC1 FMNL1 KNL1 | 9.40e-07 | 591 | 141 | 13 | 15231748 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | MYC MXD3 ONECUT2 DR1 PRRX1 MIS18BP1 POU1F1 SHOX2 THAP10 MIDEAS ZEB2 THAP4 HOXA13 HES1 PAX6 CAMTA1 | 9.41e-07 | 908 | 141 | 16 | 19274049 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | BICD2 GPHN NPR1 HAUS5 XDH DCTN1 MTPAP MPRIP ITPR1 PPP2R5D PPP2R5E TIPIN SASS6 KIF4B ATM GCN1 NEURL4 KNL1 | 1.10e-06 | 1155 | 141 | 18 | 20360068 |
| Pubmed | GPHN MICAL1 MYH10 DSP IARS1 MYO18A ARFGEF2 CORO1B AP3B1 DCTN1 PDHX MPRIP NEFM CRACD PPP2R5E PTPRA RPTOR MRPS9 MACF1 PLCH1 | 1.42e-06 | 1431 | 141 | 20 | 37142655 | |
| Pubmed | GPHN MYH10 KIF21A CORO1B CCDC6 DCTN1 ZEB2 ITIH1 MPRIP NEFM PPP2R5D RPTOR GOLGA8B MACF1 KIF4B NEURL4 | 2.01e-06 | 963 | 141 | 16 | 28671696 | |
| Pubmed | ERCC5 ATRX BMP2K POLG SUN1 BAZ1B TAB2 APOB AP3B1 DCTN1 ITPR1 PPP2R5E FMN2 MACF1 HERC1 CAMTA1 MTO1 | 2.06e-06 | 1084 | 141 | 17 | 11544199 | |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 4.37e-06 | 104 | 141 | 6 | 31240132 | |
| Pubmed | 5.47e-06 | 234 | 141 | 8 | 36243803 | ||
| Pubmed | 6.83e-06 | 407 | 141 | 10 | 12693553 | ||
| Pubmed | GPHN MYH10 RAPH1 CORO1B DCTN1 MPRIP TGFB2 CRACD PHF3 RNF20 FMN2 | 7.46e-06 | 506 | 141 | 11 | 30890647 | |
| Pubmed | 8.05e-06 | 67 | 141 | 5 | 29254152 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | MYC ONECUT2 TBC1D15 MIS18BP1 BMP2K DSP IARS1 SUN1 EI24 BAZ1B TAB2 MTPAP PPP2R5D PPP2R5E PHF3 RPTOR VTI1B | 8.13e-06 | 1203 | 141 | 17 | 29180619 |
| Pubmed | 8.62e-06 | 418 | 141 | 10 | 34709266 | ||
| Pubmed | TBC1D15 ATRX SUN1 MYO18A BAZ1B DZIP1 AP3B1 DCTN1 PDHX MPRIP ITPR1 PPP2R5D MRPS2 MRPS9 MACF1 ATM PLCH1 YME1L1 NEURL4 | 9.61e-06 | 1487 | 141 | 19 | 33957083 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYC MYH10 MIS18BP1 DSP IARS1 KIF21A BAZ1B CORO1B MIDEAS DCTN1 MTPAP MPRIP TBCB RPTOR RNF20 MACF1 GCN1 YME1L1 | 9.81e-06 | 1353 | 141 | 18 | 29467282 |
| Pubmed | MYC HAUS5 BAZ1B MTPAP PDHX NSD3 PPP2R5E DROSHA RPTOR BRPF1 FMN2 MACF1 MTO1 YME1L1 INO80B KNL1 | 1.28e-05 | 1116 | 141 | 16 | 31753913 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 10781961 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 37266952 | ||
| Pubmed | Tubulin-binding cofactor B is a direct interaction partner of the dynactin subunit p150(Glued). | 1.63e-05 | 2 | 141 | 2 | 22777741 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 12654335 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 25037575 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 23918382 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 29378238 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 17360629 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 10716990 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 18203920 | ||
| Pubmed | Atm deficiency affects both apoptosis and proliferation to augment Myc-induced lymphomagenesis. | 1.63e-05 | 2 | 141 | 2 | 17634425 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 29704870 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 19729411 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 18417613 | ||
| Pubmed | Mechanisms that can promote peripheral B-cell lymphoma in ATM-deficient mice. | 1.63e-05 | 2 | 141 | 2 | 24913718 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 24152439 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 19020088 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 24982162 | ||
| Pubmed | Nek1 Regulates Rad54 to Orchestrate Homologous Recombination and Replication Fork Stability. | 1.63e-05 | 2 | 141 | 2 | 27264870 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 27108798 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 27430888 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 10212200 | ||
| Pubmed | 1.81e-05 | 13 | 141 | 3 | 14690447 | ||
| Pubmed | 1.81e-05 | 13 | 141 | 3 | 21177258 | ||
| Pubmed | BICD2 TBC1D15 DSP IARS1 SUN1 ARFGEF2 ARFGEF1 TAB2 PPP2R5E MRPS9 | 1.86e-05 | 457 | 141 | 10 | 22190034 | |
| Pubmed | 1.86e-05 | 277 | 141 | 8 | 30745168 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.97e-05 | 202 | 141 | 7 | 33005030 | |
| Pubmed | 2.28e-05 | 285 | 141 | 8 | 32838362 | ||
| Pubmed | 2.44e-05 | 472 | 141 | 10 | 38943005 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | ARFGEF2 ARFGEF1 APOB TTF1 SLC18B1 PDHX TGFB2 TBCB USP8 PTPRA MACF1 ATM HERC1 VTI1B PROS1 | 2.85e-05 | 1061 | 141 | 15 | 33845483 |
| Pubmed | Stalled replication forks within heterochromatin require ATRX for protection. | 3.51e-05 | 16 | 141 | 3 | 27171262 | |
| Pubmed | Mouse thalamic differentiation: gli-dependent pattern and gli-independent prepattern. | 3.51e-05 | 16 | 141 | 3 | 22371696 | |
| Pubmed | A multipotent progenitor domain guides pancreatic organogenesis. | 3.58e-05 | 91 | 141 | 5 | 17609113 | |
| Pubmed | CFAP91 IARS1 TMC6 HAUS5 XDH DNAAF9 GRAMD4 ITIH1 HOXA13 USP8 PPP2R5D DISP3 YME1L1 | 3.64e-05 | 832 | 141 | 13 | 36724073 | |
| Pubmed | REPS1 ATRX BMP2K BAZ1B AP3B1 TTF1 MTPAP NSD3 MPRIP CRACD PPP2R5E MRPS2 PHF3 DROSHA IGHMBP2 MACF1 YME1L1 INO80B | 3.74e-05 | 1497 | 141 | 18 | 31527615 | |
| Pubmed | 3.78e-05 | 497 | 141 | 10 | 23414517 | ||
| Pubmed | 4.25e-05 | 17 | 141 | 3 | 15944189 | ||
| Pubmed | Shox2 function couples neural, muscular and skeletal development in the proximal forelimb. | 4.25e-05 | 17 | 141 | 3 | 21156168 | |
| Pubmed | MYH10 REPS1 IARS1 KIF21A CORO1B AP3B1 DCTN1 MTPAP MPRIP TGFB2 TBCB HOXA13 MRPS2 PHF3 IGHMBP2 GCN1 | 4.88e-05 | 1247 | 141 | 16 | 27684187 | |
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 19332778 | ||
| Pubmed | Specific functions of BIG1 and BIG2 in endomembrane organization. | 4.88e-05 | 3 | 141 | 2 | 20360857 | |
| Pubmed | PTRF/Cavin-1 promotes efficient ribosomal RNA transcription in response to metabolic challenges. | 4.88e-05 | 3 | 141 | 2 | 27528195 | |
| Pubmed | ATM promotes apoptosis and suppresses tumorigenesis in response to Myc. | 4.88e-05 | 3 | 141 | 2 | 16432227 | |
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 24303013 | ||
| Pubmed | Expression of the mouse Macf2 gene during inner ear development. | 4.88e-05 | 3 | 141 | 2 | 12399109 | |
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 16866877 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 36951067 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 19118200 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 23349395 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 21878643 | ||
| Pubmed | Involvement of BIG1 and BIG2 in regulating VEGF expression and angiogenesis. | 4.88e-05 | 3 | 141 | 2 | 31199673 | |
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 25631816 | ||
| Pubmed | Characterization of genetic changes in MCL by interphase FISH on tissue sections. | 4.88e-05 | 3 | 141 | 2 | 17613764 | |
| Pubmed | Enhancement of β-catenin activity by BIG1 plus BIG2 via Arf activation and cAMP signals. | 4.88e-05 | 3 | 141 | 2 | 27162341 | |
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 23386609 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 26049366 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 25246613 | ||
| Pubmed | Phosphorylation of SMURF2 by ATM exerts a negative feedback control of DNA damage response. | 4.88e-05 | 3 | 141 | 2 | 33097595 | |
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 36537561 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 25310835 | ||
| Pubmed | A novel TaulacZ allele reveals a requirement for Pitx2 in formation of the mammillothalamic tract. | 4.88e-05 | 3 | 141 | 2 | 21898763 | |
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 18832381 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 24623969 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 23223241 | ||
| Pubmed | Intracellular calcium release channel expression during embryogenesis. | 4.88e-05 | 3 | 141 | 2 | 9986730 | |
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 18003980 | ||
| Interaction | NHLH2 interactions | 6.90e-07 | 25 | 139 | 5 | int:NHLH2 | |
| Interaction | KIF20A interactions | MYC MYH10 MIS18BP1 DSP IARS1 HAUS5 MYO18A BAZ1B APOB CORO1B DCTN1 ZEB2 NSD3 MPRIP ITPR1 NEFM MYO1F MACF1 HERC1 GCN1 YME1L1 NEURL4 PKN3 | 8.41e-07 | 1052 | 139 | 23 | int:KIF20A |
| Interaction | CEP170P1 interactions | 1.16e-06 | 113 | 139 | 8 | int:CEP170P1 | |
| Interaction | OPALIN interactions | 1.93e-06 | 209 | 139 | 10 | int:OPALIN | |
| Interaction | CCDC65 interactions | 2.06e-06 | 14 | 139 | 4 | int:CCDC65 | |
| Interaction | WWTR1 interactions | GPHN TBC1D15 RAPH1 HAUS5 AP3B1 TTF1 DCTN1 MPRIP NEFM NEK1 PHF3 USP1 GCN1 | 7.40e-06 | 422 | 139 | 13 | int:WWTR1 |
| Interaction | NUP62 interactions | 2.03e-05 | 273 | 139 | 10 | int:NUP62 | |
| Interaction | RAD51 interactions | 4.58e-05 | 241 | 139 | 9 | int:RAD51 | |
| Interaction | ASAP1 interactions | 6.04e-05 | 98 | 139 | 6 | int:ASAP1 | |
| GeneFamily | Alpha-1,2-glucosyltransferases | 2.85e-05 | 2 | 97 | 2 | 448 | |
| GeneFamily | EF-hand domain containing|Plakins | 7.81e-04 | 8 | 97 | 2 | 939 | |
| GeneFamily | Transmembrane channel likes | 7.81e-04 | 8 | 97 | 2 | 1135 | |
| GeneFamily | PHD finger proteins | 1.40e-03 | 90 | 97 | 4 | 88 | |
| GeneFamily | THAP domain containing | 1.82e-03 | 12 | 97 | 2 | 65 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 1.92e-03 | 46 | 97 | 3 | 622 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 2.86e-03 | 15 | 97 | 2 | 696 | |
| GeneFamily | Myosin heavy chains | 2.86e-03 | 15 | 97 | 2 | 1098 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.89e-03 | 53 | 97 | 3 | 532 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | MYH10 MIS18BP1 ERCC5 IARS1 ARFGEF1 BAZ1B DZIP1 AP3B1 TTLL7 ITPR1 USP8 NEK1 PHF3 RNF20 OLFM1 ATM USP1 KNL1 PROS1 | 2.64e-09 | 656 | 141 | 19 | M18979 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MYC ATRX BMP2K ARFGEF1 BAZ1B TAB2 CCDC6 AP3B1 ZEB2 ITPR1 TGFB2 NEK1 PPP2R5E PTPRA PHF3 MACF1 DOP1B | 3.75e-06 | 856 | 141 | 17 | M4500 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | BICD2 MICAL1 DR1 MIS18BP1 GPR65 ATRX TMC6 BAZ1B TAB2 ZEB2 ITPR1 TBCB PPP2R5E PTPRA PHF3 MYO1F NLRC5 MACF1 ATM HERC1 USP1 YME1L1 FMNL1 | 4.78e-06 | 1492 | 141 | 23 | M40023 |
| Coexpression | GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_UP | 1.33e-05 | 200 | 141 | 8 | M5074 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_DN | DR1 MYH10 MIS18BP1 RAPH1 IARS1 NUP42 MTPAP ALG10B NSD3 BEND6 TIPIN ALG10 MRPS9 SASS6 MTO1 USP1 | 2.10e-05 | 877 | 141 | 16 | M2241 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | PRRX1 MYH10 MIS18BP1 REPS1 ATRX ARFGEF2 ARFGEF1 BAZ1B AP3B1 CDC14B MACF1 FMNL1 KNL1 | 3.64e-06 | 432 | 134 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 5.82e-06 | 203 | 134 | 9 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | MXD3 MYH10 REPS1 ATRX KIF21A ARFGEF2 BAZ1B AP3B1 NEK1 RNF20 FMN2 MACF1 PAX6 YME1L1 KNL1 | 1.06e-05 | 629 | 134 | 15 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 3.05e-05 | 192 | 134 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | GPHN MICAL1 MIS18BP1 REPS1 ATRX KIF21A MYO18A ARFGEF2 BAZ1B TAB2 NUP42 AP3B1 PLEKHM1 TIPIN MACF1 USP1 | 3.37e-05 | 780 | 134 | 16 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | REPS1 ATRX RAPH1 ARFGEF2 ARFGEF1 BAZ1B AP3B1 MPRIP NEK1 RNF20 MACF1 YME1L1 KNL1 | 6.01e-05 | 564 | 134 | 13 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | 6.80e-05 | 416 | 134 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_200 | 7.55e-05 | 69 | 134 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#1 | 8.98e-05 | 166 | 134 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | MYH10 REPS1 ATRX RAPH1 KIF21A ARFGEF1 BAZ1B AP3B1 MPRIP CRACD NEK1 RNF20 MACF1 | 1.03e-04 | 595 | 134 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | PRRX1 MYH10 MIS18BP1 REPS1 ATRX KIF21A ARFGEF2 ARFGEF1 BAZ1B AP3B1 CDC14B MACF1 PAX6 NEURL4 FMNL1 JHY KNL1 | 1.66e-04 | 989 | 134 | 17 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | GPHN ATRX KIF21A BAZ1B TAB2 GRIK4 AP3B1 PLEKHM1 NEFM CRACD NEK1 TIPIN FMN2 PAX6 KNL1 | 2.45e-04 | 831 | 134 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_F-vs-M_top280_280 | 2.51e-04 | 260 | 134 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_250_F-vs-M | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500 | 2.52e-04 | 89 | 134 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k2 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-07 | 195 | 141 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-07 | 195 | 141 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.44e-07 | 199 | 141 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-06 | 178 | 141 | 7 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-06 | 182 | 141 | 7 | 11494a66d986297b837332ee9d382b71b9f22591 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.77e-06 | 154 | 141 | 6 | 44d4d99b08216c0901e3bc32743fa0a8b85b5149 | |
| ToppCell | Lymphoid-Lymphoid-B_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 1.83e-05 | 172 | 141 | 6 | f39822afcc35f0fbf68b8ffd1894e4b6c8d7a80c | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 173 | 141 | 6 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 173 | 141 | 6 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 173 | 141 | 6 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | Club-club-15|World / Class top | 2.02e-05 | 175 | 141 | 6 | ca9d012f520f697c7450ec6958a015e20538a6a8 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 175 | 141 | 6 | 69b59ec58e64644deb7e07f31ef495ef4a6f6276 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 175 | 141 | 6 | 4f7498b5a0ed52c348a5f94bcd41d830ba7954ea | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.08e-05 | 176 | 141 | 6 | 75412d58438d71c49a6096bb2ef12b7f349653d8 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 184 | 141 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.67e-05 | 184 | 141 | 6 | 797b6a6d6f6aafae98f75ca8bffe8263f8d3ff9b | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.67e-05 | 184 | 141 | 6 | 77d5b60a20b277f589b18f7a131142a7ef2dac17 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.76e-05 | 185 | 141 | 6 | 097d628f92e13250c15b550f2fd1f4225fc07558 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.93e-05 | 187 | 141 | 6 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 2.93e-05 | 187 | 141 | 6 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.11e-05 | 189 | 141 | 6 | 7ccea2df93bb4b37417bbc8f6c85a61ece95211a | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.11e-05 | 189 | 141 | 6 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-05 | 190 | 141 | 6 | 4a75457652d85874d5c6a41648f8003572008b15 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-05 | 190 | 141 | 6 | cda6173634531240e0bab8766231a150ff8d0129 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-05 | 191 | 141 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.30e-05 | 191 | 141 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-05 | 191 | 141 | 6 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-05 | 191 | 141 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.49e-05 | 193 | 141 | 6 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 3.49e-05 | 193 | 141 | 6 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.70e-05 | 195 | 141 | 6 | 91a3c439f10c03c5d51d904f512b6a08040edc76 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-05 | 195 | 141 | 6 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-05 | 195 | 141 | 6 | e9c7eb0b1a2d58f69b4e839665101948bd4527b8 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.70e-05 | 195 | 141 | 6 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.86e-05 | 119 | 141 | 5 | 0cebbd44378c212aa0e18e4303f09eb315d02e11 | |
| ToppCell | T_cells-CTLs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.92e-05 | 197 | 141 | 6 | 2de34e20915a247bee75aa40495e23c20bb23e18 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.14e-05 | 199 | 141 | 6 | fbd39d34636137d1b877dd8815d58f124990136b | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_ventral_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 4.14e-05 | 199 | 141 | 6 | 446cd7d960812519fe2b8e434578ef0b668c75ce | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.14e-05 | 199 | 141 | 6 | 6977f939ddbc47d4921f36c0a61a205259fe1284 | |
| ToppCell | Non-neuronal-Dividing|World / Primary Cells by Cluster | 4.26e-05 | 200 | 141 | 6 | 50fa7b34a05f2c5ebbc7d113bd8e31326688a231 | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-CD4+_CTL|Multiple_Sclerosis / Disease, condition lineage and cell class | 4.26e-05 | 200 | 141 | 6 | 2e18ce20dc61ae90883139d1b0c29d145888c001 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Stem_cells-Neuroepithelial_cell|3m / Sample Type, Dataset, Time_group, and Cell type. | 4.26e-05 | 200 | 141 | 6 | 2938a029fa0478be561574ace91f95c4a528b2d4 | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.26e-05 | 200 | 141 | 6 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 4.26e-05 | 200 | 141 | 6 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | 4.26e-05 | 200 | 141 | 6 | 0675f580ccef705875854247bbfd4ee2bcf126a1 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-BMP_responsible_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 4.26e-05 | 200 | 141 | 6 | 5fb90118d3abc28d72bc483e68317255090a04c7 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.26e-05 | 200 | 141 | 6 | 762442d125e594fede4506b72da15563b1d8798a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Stem_cells|3m / Sample Type, Dataset, Time_group, and Cell type. | 4.26e-05 | 200 | 141 | 6 | cfe017b4a4d604a553d0a3df9659687f38e9a7af | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial-Astrocyte|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 4.26e-05 | 200 | 141 | 6 | b9bd6c4381c92bfc1bfff9aa778a62a41d08f1ef | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal-BMP_responsible_cell|3m / Sample Type, Dataset, Time_group, and Cell type. | 4.26e-05 | 200 | 141 | 6 | a4b52466b6426a835655b5fe7487e15aea816e14 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG-17|World / Primary Cells by Cluster | 4.26e-05 | 200 | 141 | 6 | 4417f14d45ce683c1a45ec989ae63ee6c047353e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Cilia-bearing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 4.26e-05 | 200 | 141 | 6 | 177f9ad8dd8635394c575a2b30140184df0bd51e | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.94e-05 | 142 | 141 | 5 | b66f9602dba30d1d4fbcc49ceb112eb5bd916ba1 | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Igfbp2)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.34e-04 | 82 | 141 | 4 | 89aff8676f98e062d0e69b38c7184e51aa1a915e | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Igfbp2)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.34e-04 | 82 | 141 | 4 | 6875a10abf1221b3dfd954c319b5e8e12fac1ff2 | |
| ToppCell | Substantia_nigra-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Igfbp2_(Igfbp2)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.34e-04 | 82 | 141 | 4 | 259bb4ae0373d8352cb1c3bff08f66b89a298440 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 155 | 141 | 5 | 72a19a9ecfd13f6769c4b447d3ce01a855ec6ec7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 160 | 141 | 5 | fe9970c160159b35f6599ed13c89cfb49264d554 | |
| ToppCell | Club_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.61e-04 | 161 | 141 | 5 | 342f5c61d37df61b35c18f5d258043a8f5cef629 | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-04 | 161 | 141 | 5 | a7e74bc80ac11250e353e5614b19c05793fc2e95 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-04 | 163 | 141 | 5 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 163 | 141 | 5 | 953a7db7e90a913e81002d2141fbbd5f1fdf2197 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.71e-04 | 163 | 141 | 5 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.86e-04 | 166 | 141 | 5 | ceb0a48c0d853448fd45ac31dde046df9a178571 | |
| ToppCell | normal_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th|normal_Lung / Location, Cell class and cell subclass | 1.86e-04 | 166 | 141 | 5 | ff32422390852546e0cb216192452e9c47bd9509 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 168 | 141 | 5 | ce5e92a1df3acfa5cd8d5a134e4af231dc592a13 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 168 | 141 | 5 | 22c89d4eb44573f6301069ec7ca7cbd0dd958403 | |
| ToppCell | Basal_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.96e-04 | 168 | 141 | 5 | 48089fa2d4a0f31a72405717119b767a92571f01 | |
| ToppCell | Ionocyte-iono-1|World / Class top | 2.02e-04 | 169 | 141 | 5 | 4b68bcb4b5fc3cd2db23cd4edace7444aa2d605c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-04 | 170 | 141 | 5 | 928e42c51a7079c506f21c669c4e4c1a0df84d77 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.13e-04 | 171 | 141 | 5 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.19e-04 | 172 | 141 | 5 | 3a37569a5902f3c65ff8d3912421309a8c82ee9b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.19e-04 | 172 | 141 | 5 | cc9d9dae290f11f8c348c78228af4e49469dc93b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.25e-04 | 173 | 141 | 5 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.31e-04 | 174 | 141 | 5 | 271c51d220842402975d97c86c9acfdbdf62a32c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-04 | 174 | 141 | 5 | b6e3fa995def40a8fbdfc249fe108c303931a171 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Mgp_(Mgp)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.36e-04 | 95 | 141 | 4 | 53dde5363ea1d64386234e5bd4fbb28c057f2f21 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Mgp_(Mgp)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.36e-04 | 95 | 141 | 4 | ef0b7289b348617a76b4643479adc7e9701c0094 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Mgp_(Mgp)--|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.36e-04 | 95 | 141 | 4 | 8b4d6b25ce28811a76ea11713d881117e495ef5e | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.43e-04 | 176 | 141 | 5 | 1510cdfcfb46ce1196a1220c07fb5f3986c81b78 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.43e-04 | 176 | 141 | 5 | bfa1633e1b7a8a2f04d37fa07284fe9bc0199f46 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.50e-04 | 177 | 141 | 5 | 8a74f5e72de605774111057bd87a7e7e4a6385cd | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.50e-04 | 177 | 141 | 5 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.63e-04 | 179 | 141 | 5 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | ASK454-Epithelial-Ciliated|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.63e-04 | 179 | 141 | 5 | f21919ef9d3d984e2925ef3d24f89e20fe265dcd | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.70e-04 | 180 | 141 | 5 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-04 | 181 | 141 | 5 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 184 | 141 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.99e-04 | 184 | 141 | 5 | 2df903924df9cb71039159416bcbe6a6614e21fe | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 184 | 141 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 184 | 141 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL14A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.06e-04 | 185 | 141 | 5 | 506eee2c1b6e8acec3aa8b2c66868010006c4c14 | |
| ToppCell | CV-Healthy-7|Healthy / Virus stimulation, Condition and Cluster | 3.06e-04 | 185 | 141 | 5 | 1979d189c204f4c2893e3170a514ee7d5523406c | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.06e-04 | 185 | 141 | 5 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-04 | 185 | 141 | 5 | 45890fa81c65a48f4fdec164a4c8d0e2831243c0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-04 | 185 | 141 | 5 | 585bcfdff85bf43f5aa4cd1b39f7dcf1c78d7b02 | |
| ToppCell | Control-T_cells-NK_cells|Control / group, cell type (main and fine annotations) | 3.06e-04 | 185 | 141 | 5 | 755c0998c729f462399f1d5e88adf4bfae31be30 | |
| ToppCell | droplet-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-04 | 186 | 141 | 5 | 26f1e9930adf2fe4af0819e56f69915bd8330e4a | |
| ToppCell | Primary_Motor_Cortex_(M1)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.22e-04 | 187 | 141 | 5 | 892a4d439a0aa90f254dd17e1edce1fdc3619510 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.22e-04 | 187 | 141 | 5 | 42b20d7f0a4f9195b3d71dc0e089b5e0914ebcbb | |
| Drug | Convolamine hydrochloride [500-56-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | POLG BAZ1B AP3B1 DCTN1 CDC14B GRAMD4 NSD3 TTLL7 ITPR1 INO80B | 4.16e-07 | 199 | 139 | 10 | 5876_DN |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 2.85e-06 | 192 | 139 | 9 | 5509_DN | |
| Drug | Famprofazone [22881-35-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 3.38e-06 | 196 | 139 | 9 | 6029_DN | |
| Drug | Etofenamate [30544-47-9]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 3.38e-06 | 196 | 139 | 9 | 4108_DN | |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Up 200; 9uM; PC3; HT_HG-U133A | 3.67e-06 | 198 | 139 | 9 | 5096_UP | |
| Drug | Urosiol [128-13-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 3.98e-06 | 200 | 139 | 9 | 6484_DN | |
| Drug | bilirubin ditaurate | 4.39e-06 | 6 | 139 | 3 | CID006441998 | |
| Drug | nocodazole | BICD2 GPHN MXD3 MICAL1 MYH10 MYO18A ARFGEF2 ARFGEF1 DCTN1 GRAMD4 ITPR1 PPP2R5D PPP2R5E | 7.54e-06 | 477 | 139 | 13 | CID000004122 |
| Drug | T0702 | 1.52e-05 | 25 | 139 | 4 | CID000005908 | |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A | 2.09e-05 | 188 | 139 | 8 | 4545_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | 2.17e-05 | 189 | 139 | 8 | 4271_DN | |
| Drug | Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 2.43e-05 | 192 | 139 | 8 | 6054_DN | |
| Drug | Ethisterone [434-03-7]; Up 200; 12.8uM; PC3; HT_HG-U133A | 2.43e-05 | 192 | 139 | 8 | 4340_UP | |
| Drug | Dichlorphenamide [120-97-8]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 2.61e-05 | 194 | 139 | 8 | 3366_DN | |
| Drug | Pridinol methanesulfonate salt [6856-31-1]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 2.71e-05 | 195 | 139 | 8 | 3456_UP | |
| Drug | Cholecalciferol [67-97-0]; Down 200; 10.4uM; HL60; HT_HG-U133A | 2.81e-05 | 196 | 139 | 8 | 2436_DN | |
| Drug | Meticrane [1084-65-7]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 2.81e-05 | 196 | 139 | 8 | 5984_DN | |
| Drug | Zardaverine [101975-10-4]; Down 200; 15uM; MCF7; HT_HG-U133A | 2.81e-05 | 196 | 139 | 8 | 4793_DN | |
| Drug | Pirlindole mesylate [60762-57-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 2.92e-05 | 197 | 139 | 8 | 6519_DN | |
| Drug | Carbamazepine [298-46-4]; Down 200; 17uM; MCF7; HT_HG-U133A | 2.92e-05 | 197 | 139 | 8 | 5518_DN | |
| Drug | pioglitazone HCl; Up 200; 10uM; MCF7; HT_HG-U133A | 2.92e-05 | 197 | 139 | 8 | 5925_UP | |
| Drug | Pralidoxime chloride [51-15-0]; Down 200; 23.2uM; MCF7; HT_HG-U133A | 2.92e-05 | 197 | 139 | 8 | 6443_DN | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; PC3; HG-U133A | 2.92e-05 | 197 | 139 | 8 | 1923_DN | |
| Drug | Imidurea [39236-46-9]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 2.92e-05 | 197 | 139 | 8 | 5481_DN | |
| Drug | Isoflupredone acetate [338-98-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 3.02e-05 | 198 | 139 | 8 | 5545_DN | |
| Drug | Butylparaben [94-26-8]; Down 200; 20.6uM; MCF7; HT_HG-U133A | 3.02e-05 | 198 | 139 | 8 | 6446_DN | |
| Drug | Fluorocurarine chloride [22273-09-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 3.13e-05 | 199 | 139 | 8 | 6219_DN | |
| Drug | Meropenem [96036-03-2]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 3.13e-05 | 199 | 139 | 8 | 3564_DN | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 3.13e-05 | 199 | 139 | 8 | 1648_DN | |
| Drug | Norethynodrel [68-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 3.13e-05 | 199 | 139 | 8 | 7471_DN | |
| Drug | Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 3.25e-05 | 200 | 139 | 8 | 3577_DN | |
| Drug | papaverine | 1.06e-04 | 176 | 139 | 7 | CID000004680 | |
| Drug | E3040 sulfate | 1.11e-04 | 3 | 139 | 2 | CID000443293 | |
| Drug | hydroxyoctanoate | 1.13e-04 | 41 | 139 | 4 | CID000094180 | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 1.14e-04 | 178 | 139 | 7 | 3998_DN | |
| Drug | Ganciclovir [82410-32-0]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 1.54e-04 | 187 | 139 | 7 | 3368_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 1.54e-04 | 187 | 139 | 7 | 2474_UP | |
| Drug | Prostaglandin E1; Up 200; 10uM; PC3; HT_HG-U133A | 1.70e-04 | 190 | 139 | 7 | 6571_UP | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 1.76e-04 | 191 | 139 | 7 | 4303_DN | |
| Drug | Triprolidine hydrochloride [550-70-9]; Up 200; 12.8uM; PC3; HT_HG-U133A | 1.82e-04 | 192 | 139 | 7 | 7248_UP | |
| Drug | Boldine [476-70-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.88e-04 | 193 | 139 | 7 | 4122_UP | |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; HL60; HT_HG-U133A | 1.88e-04 | 193 | 139 | 7 | 2366_DN | |
| Drug | phenanthridinone; Up 200; 51.2uM; MCF7; HT_HG-U133A_EA | 1.88e-04 | 193 | 139 | 7 | 1115_UP | |
| Drug | Ethopropazine hydrochloride [1094-08-2]; Down 200; 11.4uM; PC3; HT_HG-U133A | 1.88e-04 | 193 | 139 | 7 | 6697_DN | |
| Drug | Iodixanol [92339-11-2]; Down 200; 2.6uM; MCF7; HT_HG-U133A | 1.94e-04 | 194 | 139 | 7 | 4848_DN | |
| Drug | Propantheline bromide [50-34-0]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.94e-04 | 194 | 139 | 7 | 4798_UP | |
| Drug | Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; PC3; HT_HG-U133A | 1.94e-04 | 194 | 139 | 7 | 4642_UP | |
| Drug | Homocysteine | 2.00e-04 | 195 | 139 | 7 | ctd:D006710 | |
| Drug | Minocycline hydrochloride [13614-98-7]; Down 200; 8uM; PC3; HT_HG-U133A | 2.00e-04 | 195 | 139 | 7 | 5077_DN | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 2.00e-04 | 195 | 139 | 7 | 1505_DN | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.00e-04 | 195 | 139 | 7 | 3893_DN | |
| Drug | Lobelanidine hydrochloride [6112-86-3]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 2.06e-04 | 196 | 139 | 7 | 2897_DN | |
| Drug | Clorsulon [60200-06-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.06e-04 | 196 | 139 | 7 | 7025_UP | |
| Drug | Niacin [59-67-6]; Up 200; 32.4uM; MCF7; HT_HG-U133A | 2.06e-04 | 196 | 139 | 7 | 5301_UP | |
| Drug | Thioproperazine dimesylate [2347-80-0]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 2.06e-04 | 196 | 139 | 7 | 2236_DN | |
| Drug | Gemfibrozil [25812-30-0]; Down 200; 16uM; PC3; HT_HG-U133A | 2.06e-04 | 196 | 139 | 7 | 2113_DN | |
| Drug | Mafenide hydrochloride [138-37-4]; Down 200; 18uM; MCF7; HT_HG-U133A | 2.06e-04 | 196 | 139 | 7 | 5499_DN | |
| Drug | Sulfisoxazole [127-69-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 2.06e-04 | 196 | 139 | 7 | 5257_DN | |
| Drug | Meclocycline sulfosalicylate [73816-42-9]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 2.06e-04 | 196 | 139 | 7 | 3277_UP | |
| Drug | Alexidine dihydrochloride [22573-93-9]; Down 200; 6.8uM; PC3; HT_HG-U133A | 2.06e-04 | 196 | 139 | 7 | 3699_DN | |
| Drug | Chelidonine monohydrate (+) [476-32-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 2.06e-04 | 196 | 139 | 7 | 6236_DN | |
| Drug | Tetracaone hydrochloride [136-47-0]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 2.06e-04 | 196 | 139 | 7 | 2888_DN | |
| Drug | Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 2.06e-04 | 196 | 139 | 7 | 3420_DN | |
| Drug | S-(+)-ibuprofen [51146-56-6]; Down 200; 19.4uM; MCF7; HT_HG-U133A | 2.06e-04 | 196 | 139 | 7 | 6471_DN | |
| Drug | Panthenol (D) [81-13-0]; Up 200; 19.4uM; PC3; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 1802_UP | |
| Drug | Foliosidine [2520-38-9]; Down 200; 13uM; MCF7; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 4761_DN | |
| Drug | Chenodiol [474-25-9]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 6012_DN | |
| Drug | Myricetin [529-44-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 3270_DN | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; PC3; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 1217_UP | |
| Drug | Moxonidine [75438-57-2]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 7343_UP | |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 3750_DN | |
| Drug | Piperacillin sodium salt [59703-84-3]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 3939_DN | |
| Drug | Levopropoxyphene napsylate [5714-90-9]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 5503_DN | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; PC3; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 1223_UP | |
| Drug | Dihydrostreptomycin sulfate [5490-27-7]; Up 200; 2.8uM; MCF7; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 2237_UP | |
| Drug | Idazoxan hydrochloride [79944-56-2]; Up 200; 16.6uM; HL60; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 3088_UP | |
| Drug | Betonicine [515-25-3]; Down 200; 25.2uM; MCF7; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 6063_DN | |
| Drug | Indomethacin [53-86-1]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 5468_DN | |
| Drug | verapamil | MYH10 MYO18A APOB RYR1 ITPR1 TGFB2 RPTOR SCNN1B ABCC2 YME1L1 PKN3 | 2.16e-04 | 490 | 139 | 11 | CID000002520 |
| Drug | Tridihexethyl chloride; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.19e-04 | 198 | 139 | 7 | 5486_DN | |
| Drug | Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 2.19e-04 | 198 | 139 | 7 | 2653_DN | |
| Drug | Ozagrel hydrochloride [78712-43-3]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 2.19e-04 | 198 | 139 | 7 | 5983_DN | |
| Drug | Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; PC3; HT_HG-U133A | 2.19e-04 | 198 | 139 | 7 | 7366_DN | |
| Drug | Lidocaone hydrochloride [73-78-9]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 2.19e-04 | 198 | 139 | 7 | 1499_UP | |
| Drug | SB 203580; Down 200; 1uM; PC3; HT_HG-U133A | 2.19e-04 | 198 | 139 | 7 | 7066_DN | |
| Drug | Cefaclor [70356-03-5]; Down 200; 10.4uM; PC3; HT_HG-U133A | 2.19e-04 | 198 | 139 | 7 | 6622_DN | |
| Drug | Bromopride [4093-35-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.19e-04 | 198 | 139 | 7 | 6037_DN | |
| Drug | Tocainide hydrochloride; Down 200; 17.4uM; MCF7; HT_HG-U133A | 2.19e-04 | 198 | 139 | 7 | 4838_DN | |
| Drug | Risperidone [106266-06-2]; Up 200; 9.8uM; HL60; HT_HG-U133A | 2.19e-04 | 198 | 139 | 7 | 2947_UP | |
| Drug | AC1L3UXH | 2.20e-04 | 4 | 139 | 2 | CID000065446 | |
| Drug | picrolonic acid | 2.20e-04 | 4 | 139 | 2 | CID000068369 | |
| Drug | 3-(4-methylpiperazin)-8-oxo-8H-acenaphtho(1,2-b)pyrrole-9-carbonitrile | 2.20e-04 | 4 | 139 | 2 | ctd:C553472 | |
| Drug | Fusidic acid sodium salt [751-94-0]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 2.26e-04 | 199 | 139 | 7 | 5353_DN | |
| Drug | Estrone [53-16-7]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 2.26e-04 | 199 | 139 | 7 | 6448_DN | |
| Drug | Pentetic acid [67-43-6]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 2.26e-04 | 199 | 139 | 7 | 5264_UP | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Up 200; 9uM; PC3; HT_HG-U133A | 2.26e-04 | 199 | 139 | 7 | 6660_UP | |
| Drug | Clemizole hydrochloride [1163-36-6]; Down 200; 11uM; MCF7; HT_HG-U133A | 2.26e-04 | 199 | 139 | 7 | 4695_DN | |
| Drug | Prednicarbate [73771-04-7]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 2.26e-04 | 199 | 139 | 7 | 5544_UP | |
| Drug | Scopolamine hydrochloride [55-16-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.26e-04 | 199 | 139 | 7 | 4803_DN | |
| Drug | Fenoterol hydrobromide [1944-12-3]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 2.33e-04 | 200 | 139 | 7 | 5432_UP | |
| Disease | nonsyndromic deafness (implicated_via_orthology) | 2.02e-06 | 6 | 139 | 3 | DOID:0050563 (implicated_via_orthology) | |
| Disease | HIV infection | 2.20e-05 | 2 | 139 | 2 | EFO_0000764 | |
| Disease | Gillespie syndrome | 2.20e-05 | 2 | 139 | 2 | C0431401 | |
| Disease | osteochondrodysplasia (biomarker_via_orthology) | 2.20e-05 | 2 | 139 | 2 | DOID:2256 (biomarker_via_orthology) | |
| Disease | response to selective serotonin reuptake inhibitor | 4.40e-05 | 82 | 139 | 5 | EFO_0005658 | |
| Disease | Long Qt Syndrome 2 | 6.59e-05 | 3 | 139 | 2 | C3150943 | |
| Disease | aspartate aminotransferase measurement | ONECUT2 ARHGEF19 SUN1 XDH ITIH1 PLEKHM1 TTLL7 ITPR1 USP8 TRPM3 NLRC5 PNPLA3 ABCC2 GCN1 | 9.84e-05 | 904 | 139 | 14 | EFO_0004736 |
| Disease | glucagon measurement, glucose tolerance test | 3.26e-04 | 6 | 139 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | Childhood Oligodendroglioma | 4.56e-04 | 7 | 139 | 2 | C0280475 | |
| Disease | Adult Oligodendroglioma | 4.56e-04 | 7 | 139 | 2 | C0279070 | |
| Disease | Oligodendroblastoma | 4.56e-04 | 7 | 139 | 2 | C0344461 | |
| Disease | Mixed Oligodendroglioma-Astrocytoma | 4.56e-04 | 7 | 139 | 2 | C0280793 | |
| Disease | Mixed Oligodendroglioma-Ependymoma | 4.56e-04 | 7 | 139 | 2 | C0751395 | |
| Disease | Well Differentiated Oligodendroglioma | 4.56e-04 | 7 | 139 | 2 | C0751396 | |
| Disease | oligodendroglioma | 6.06e-04 | 8 | 139 | 2 | C0028945 | |
| Disease | FEV change measurement, fatty liver disease | 6.06e-04 | 8 | 139 | 2 | EFO_0005921, MONDO_0004790 | |
| Disease | dynein light chain roadblock-type 1 measurement | 6.06e-04 | 8 | 139 | 2 | EFO_0008114 | |
| Disease | Anaplastic Oligodendroglioma | 6.06e-04 | 8 | 139 | 2 | C0334590 | |
| Disease | sarcoma (is_implicated_in) | 6.06e-04 | 8 | 139 | 2 | DOID:1115 (is_implicated_in) | |
| Disease | triglycerides to total lipids in large VLDL percentage | 8.26e-04 | 39 | 139 | 3 | EFO_0022332 | |
| Disease | cysteine-glutathione disulfide measurement | 1.18e-03 | 11 | 139 | 2 | EFO_0021001 | |
| Disease | neutropenia, response to gemcitabine | 1.18e-03 | 11 | 139 | 2 | GO_0036272, MONDO_0001475 | |
| Disease | level of Ceramide (d42:2) in blood serum | 1.41e-03 | 12 | 139 | 2 | OBA_2045186 | |
| Disease | response to hydrochlorothiazide, triglyceride measurement | 1.43e-03 | 47 | 139 | 3 | EFO_0004530, EFO_0005202 | |
| Disease | coronary artery disease | REPS1 ARFGEF2 CENPO TAB2 APOB GRIK4 ZEB2 CRACD TRPM3 RPTOR FMN2 KIF4B PNPLA3 DLEC1 | 1.56e-03 | 1194 | 139 | 14 | EFO_0001645 |
| Disease | Autosomal recessive primary microcephaly | 2.22e-03 | 15 | 139 | 2 | cv:C3711387 | |
| Disease | triglycerides to total lipids in chylomicrons and extremely large VLDL percentage | 2.22e-03 | 15 | 139 | 2 | EFO_0022328 | |
| Disease | mean corpuscular hemoglobin concentration | DR1 BMP2K TRIM58 TMC6 ARFGEF2 CORO1B MIDEAS ZEB2 RNF20 MACF1 KIF4B PNPLA3 USP1 | 2.22e-03 | 1105 | 139 | 13 | EFO_0004528 |
| Disease | phospholipids in medium HDL measurement | 2.24e-03 | 55 | 139 | 3 | EFO_0022295 | |
| Disease | apolipoprotein A 1 measurement | DR1 REPS1 APOB MIDEAS ITIH1 NLRC5 MACF1 PNPLA3 DLEC1 HERC1 USP1 | 2.31e-03 | 848 | 139 | 11 | EFO_0004614 |
| Disease | total lipids in medium HDL measurement | 2.61e-03 | 58 | 139 | 3 | EFO_0022310 | |
| Disease | free cholesterol in medium HDL measurement | 2.61e-03 | 58 | 139 | 3 | EFO_0022267 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.62e-03 | 121 | 139 | 4 | EFO_0008595, EFO_0020943 | |
| Disease | Prostatic Neoplasms | 2.64e-03 | 616 | 139 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.64e-03 | 616 | 139 | 9 | C0376358 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 2.86e-03 | 17 | 139 | 2 | EFO_0022232 | |
| Disease | cholesterol to total lipids in IDL percentage | 2.88e-03 | 60 | 139 | 3 | EFO_0022233 | |
| Disease | phospholipids in HDL measurement | 3.02e-03 | 61 | 139 | 3 | EFO_0022293 | |
| Disease | hip bone mineral density | 3.03e-03 | 126 | 139 | 4 | EFO_0007702 | |
| Disease | platelet component distribution width | BMP2K TRIM58 RIPOR3 MPRIP KIF9 TRPM3 MACF1 DLEC1 HERC1 CAMTA1 | 3.14e-03 | 755 | 139 | 10 | EFO_0007984 |
| Disease | Tourette syndrome, schizophrenia | 3.21e-03 | 18 | 139 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | non-alcoholic fatty liver disease (is_implicated_in) | 3.21e-03 | 18 | 139 | 2 | DOID:0080208 (is_implicated_in) | |
| Disease | total lipids in HDL measurement | 3.30e-03 | 63 | 139 | 3 | EFO_0022307 | |
| Disease | blood metabolite measurement | 3.57e-03 | 19 | 139 | 2 | EFO_0005664 | |
| Disease | cardiomyopathy (is_implicated_in) | 3.57e-03 | 19 | 139 | 2 | DOID:0050700 (is_implicated_in) | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 3.93e-03 | 67 | 139 | 3 | EFO_0008595, EFO_0020946 | |
| Disease | Adenocarcinoma of prostate | 3.96e-03 | 20 | 139 | 2 | C0007112 | |
| Disease | serum gamma-glutamyl transferase measurement | ARHGEF19 PDE4C REPS1 ATRX BAZ1B PDHX MPRIP ITPR1 ABCC2 GCN1 PKN3 | 4.08e-03 | 914 | 139 | 11 | EFO_0004532 |
| Disease | apolipoprotein B measurement | 4.28e-03 | 663 | 139 | 9 | EFO_0004615 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 4.34e-03 | 225 | 139 | 5 | EFO_0008317, EFO_0020947 | |
| Disease | skin hydration measurement | 4.36e-03 | 21 | 139 | 2 | EFO_0009586 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 4.36e-03 | 21 | 139 | 2 | EFO_0022246 | |
| Disease | phospholipids:total lipids ratio | 4.50e-03 | 227 | 139 | 5 | EFO_0020946 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SLVNEQSQITRRKKR | 41 | Q15361 | |
| SVRKARQKRSQSSSQ | 21 | Q16537 | |
| SLQNNIRTSLEKKRR | 796 | Q9P2K9 | |
| ARRTAVIVQQKLRSS | 1616 | Q9Y6Y1 | |
| LREAQSDLNKTRLRS | 501 | Q5VTR2 | |
| ALRRLQASKERQTAL | 396 | Q8TD16 | |
| AELKQRLNSQSKRTI | 1031 | Q14203 | |
| LRALKSRRQSKTNAI | 431 | O60729 | |
| VLQTKRSSRRQSLEL | 1331 | Q9UIG0 | |
| SSKQNVASEKQRRLL | 896 | Q9Y6D6 | |
| RTQARAASQKNLVRL | 311 | Q8IXS2 | |
| QLKERSSAAVSRRLQ | 401 | Q6IC98 | |
| STKQNVASEKQRRLL | 841 | Q9Y6D5 | |
| QRDLKISRRNVLSDS | 401 | Q9BR76 | |
| VKKERRQSSSRFNLS | 81 | Q14738 | |
| RNKAASSIQRVLSTL | 121 | Q5I7T1 | |
| NRDLRKASVTIQARA | 91 | Q16204 | |
| QIRLTLRKFNRENSS | 796 | P16066 | |
| KQRSLQKLSSRQRRT | 971 | Q9NSY1 | |
| LTNTRKENSRLRQSL | 81 | Q5SZJ8 | |
| ANIQATLIRSRLRKV | 56 | Q7Z4T9 | |
| SKSLVRLLRSNREVQ | 336 | O00203 | |
| ESSQSRLERLRNKII | 576 | Q2M243 | |
| LADLNRTLQRKSITR | 1166 | Q70E73 | |
| TRLQRRVQDLQKLTS | 391 | Q6PCD5 | |
| KIRDSNRSTLLATIQ | 521 | Q9NQX3 | |
| SRSRQLLREDKKVNN | 1031 | Q9UPP5 | |
| LRNLRENKRVTSATS | 781 | Q8IW93 | |
| LKRKLQRNRTSFTQE | 206 | P26367 | |
| KKSLRLSSDQIRRLN | 591 | Q9BQK8 | |
| TRQLRNIRSKSVIEQ | 1006 | Q6WCQ1 | |
| ARQLKERLRSKQQSL | 116 | Q9BW11 | |
| ARNKTLTRAQLAKQI | 236 | Q6P0N0 | |
| LSSERSQRNQVKISR | 606 | Q6NUN7 | |
| KTNNAISSKREILRR | 701 | Q96PY6 | |
| TDRSQILKNVRNAIR | 411 | P19827 | |
| SASVRKSRKQQQRLL | 1201 | Q14643 | |
| NLLRFVKTTQRRQSA | 681 | Q9Y2Z2 | |
| ELQALTTSRLLKQQR | 1201 | Q9Y3R5 | |
| TTSRLLKQQRERQEA | 1206 | Q9Y3R5 | |
| ASRRSQKRLQSPSKQ | 486 | Q76MJ5 | |
| KNLELIQTRSSSRDR | 1311 | Q15751 | |
| RIRTKSSNTALLNRE | 96 | Q9NYQ8 | |
| QSKLAQRRQRASLSS | 441 | Q9HBH9 | |
| SAVLRISQRQRQSKA | 221 | Q8NGZ2 | |
| SNIRRVIAKRLTESK | 281 | O00330 | |
| FNLNRSSKRESKTRL | 46 | Q92614 | |
| NLQRRASQKELRKSF | 111 | Q9HCR9 | |
| IFQNLSAKQRLSLRR | 476 | Q08493 | |
| LQVLSDLVRKARSRN | 66 | Q9NST1 | |
| SRDARTKQLRQLLEK | 86 | Q99784 | |
| QKKSRLVFTDLQRRT | 426 | O95948 | |
| SLQDLRKVQRETARK | 1021 | P54098 | |
| TSSKALRTLEQARQL | 1676 | O94854 | |
| ESNALRNKKNSRRVS | 46 | Q8NG31 | |
| SKLQRTLQRSRAKEN | 636 | Q8TDZ2 | |
| SLRNSLKTRNVNSLK | 926 | Q92887 | |
| RRQAQQTVRKLLSSL | 581 | Q92616 | |
| IRKSTNLLLTRTLSN | 526 | Q9Y2D4 | |
| SILNERRKRASETTQ | 601 | Q9HAQ2 | |
| SQRSTLLKERQVLTQ | 306 | O94927 | |
| LKLKNQTSERSRVRS | 151 | Q9NVV4 | |
| TVALKRRKASSRLEN | 96 | Q01658 | |
| TRAASNAILASQRRK | 211 | Q86Y01 | |
| QRKGAQSRSLTLRLQ | 836 | Q86WI3 | |
| SKALRTLEQARQLAT | 5551 | Q9UPN3 | |
| LTARQRALLQKARSQ | 176 | Q9C086 | |
| RNRVNELKSLNISTK | 186 | O15504 | |
| NTLLQRNTETRKRKL | 2736 | Q13315 | |
| TLREVSSKLRRNLQN | 4096 | P04114 | |
| ERRNLSSKRNTKEIQ | 1136 | P46100 | |
| RNSLRTSTKRKQADI | 1186 | P46100 | |
| SSVLAQRRAQSIERK | 46 | O14681 | |
| SRLERREQLKKANTL | 1161 | Q6ZU35 | |
| RLKNTLTQTTENLRR | 1411 | P15924 | |
| RLRQVQSILTQSSKS | 31 | Q5TEA3 | |
| RSRRAAAVKATQTLQ | 961 | Q6PJG2 | |
| SRKALRNSRIVSQKD | 211 | O95466 | |
| RNFQKQSSVLRRKTE | 691 | Q2VIQ3 | |
| LERLETQVSRSRKQS | 21 | Q9BU64 | |
| AVLNSRSIKISRLND | 76 | A8MQT2 | |
| ERLSITLAKNRINRA | 41 | Q16099 | |
| KQRSLQKLSSRQRRT | 221 | Q5H9B9 | |
| RASVFSNLRIRKNLS | 71 | Q9NZ56 | |
| LRSTARKQLIIRNAT | 626 | Q9Y238 | |
| RTKQEVLSLRRENST | 291 | Q6UVJ0 | |
| VALAKSLRQRRAQAS | 556 | P51168 | |
| EEKQSKLRSLRNRQS | 461 | P21817 | |
| EETRQKLNLSSRIRQ | 1326 | P35580 | |
| TLIKLSNNNKTAERR | 326 | Q96JN8 | |
| LLVTNTRENKSRQIR | 676 | P18433 | |
| VKLLSSRRTQDRKAL | 201 | Q6P5Z2 | |
| RRARINESLSQLKTL | 46 | Q14469 | |
| SLKQLLQRQRTALTS | 171 | Q9NQF3 | |
| IRRNQKLTASSLSLD | 241 | Q9Y4G2 | |
| LLRSSLVNNRTQAKV | 1176 | Q9NRR4 | |
| SIRRNKETNTVLARL | 751 | Q96D71 | |
| NLTRRRLKRSNSISQ | 571 | Q9NYJ8 | |
| SRRKRSKSQNILSTE | 431 | Q6NT16 | |
| RQREKRVKTSLNQSL | 266 | P28069 | |
| KLDSVRVLRQISNNR | 326 | P01106 | |
| QTLVKRRQRKDLASS | 86 | P28715 | |
| TKIKQRRSRTNFTLE | 136 | O60902 | |
| RSRKLKLFLNETQTQ | 1221 | P41252 | |
| RLFQTAITRAKEKRQ | 251 | Q9Y399 | |
| QASQVLVRKRRANSL | 31 | P07225 | |
| RQLIRQKAVSTDRTS | 641 | Q86YF9 | |
| KRRRISATTNLSERQ | 351 | P31271 | |
| IRAVATARSLNKSLQ | 726 | Q8N122 | |
| LSKITNRLTIQRKSQ | 521 | P55201 | |
| RNKAASSIQRVLSTL | 121 | Q5BKT4 | |
| VEVQVKRRRTASLSN | 21 | Q9Y675 | |
| LESQQTNRRKKRALD | 291 | P61812 | |
| LSSKRKQISRDINRI | 906 | A0JNW5 | |
| VQRFRRSVTLESKKQ | 241 | P82933 | |
| LKRQVQKSRARSSSL | 466 | Q0P670 | |
| AQSRRIAKSINRNSV | 31 | Q96MK2 | |
| LTESRRNREIAQLKK | 786 | Q7Z4S6 | |
| RRLDKKLSELSNQRT | 971 | P38935 | |
| KLSELSNQRTSRRKE | 976 | P38935 | |
| ISDKLDRQRNTASLR | 1681 | Q9HCF6 | |
| QRQDTVRSFLKRSKL | 116 | Q99426 | |
| EQVRSLRQSTIAKRS | 136 | Q92576 | |
| NRTISALKTTQRQLS | 461 | P47989 | |
| KSISQEQEKRNSRLR | 391 | Q8TC07 | |
| QRQRKRILSVSTKDT | 316 | Q8IYL9 | |
| SVEKKQQRRSIRTRS | 571 | Q9BZ95 | |
| RKLSSRSQSRVRNIA | 1576 | Q4KWH8 | |
| ESQSRLNQILRIKTS | 456 | Q9H6N6 | |
| ALTQKTNDSLRRTRL | 281 | Q96TA2 | |
| ASRLQQDNIRTRLKE | 396 | Q7Z403 | |
| KATQSQRRNSSKTRA | 711 | Q8NEE8 | |
| VSLKNRAARTTKQRR | 81 | O94901 | |
| SLSRANAQLRKKIQV | 781 | Q8TDI7 | |
| QSLTTDSRRQISNIK | 541 | O60315 | |
| KRKQRRNRTTFNSSQ | 91 | P54821 | |
| SSVIQKNLRFSQRLR | 66 | Q9P2Z0 | |
| RDQLERTKSRLVNTS | 171 | Q9UEU0 | |
| KAEISRLSASQIRNL | 751 | P40818 | |
| LRQRVSRSDSQVRKL | 376 | Q8WY91 | |
| LERRQAKLLSNSQTL | 211 | Q9BVW5 | |
| TLQRLRESKSRLVQQ | 211 | Q8NG06 | |
| NQRQTRSKRKATSDT | 296 | O94782 | |
| KLLNIRTSDKRRNLA | 376 | Q6ZT98 | |
| SNILLNKKERRRNSI | 721 | O00160 | |
| SIDIQLNRRQSTAKK | 436 | Q9NR99 | |
| RRQLQSKSIELESVR | 321 | P07197 |